SI-BONE Inc.

Last updated September 27, 2026

Organization details

Legal name
SI-BONE Inc.
Ownership
Public
Status
Active
SIC code
3841 — Surgical & Medical Instruments & Apparatus
Jurisdiction of incorporation
Delaware
Headquarters city
Santa Clara
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
SIBN
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001459839
EIN
26-2216351

Board of directors

Chief executives

Laura Francis · Chief Executive Officer
Dates unknown

Director election results

Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

7 of this board's directors also sit on 13 other boards.

Network of SI-BONE Inc.'s board connections Orthofix Medical Inc. Orthofix Medical Inc. Accuray Incorporated Accuray Incorporated Alphatec Holdings Inc. Alphatec Holdings Inc. Bio-Rad Laboratories Inc. Bio-Rad Laboratories I... Bruker Corporation Bruker Corporation CeriBell Inc. CeriBell Inc. Collegium Pharmaceutical Inc. Collegium Pharmaceutic... Inogen Inc Inogen Inc Minerva Neurosciences Inc Minerva Neurosciences... NovoCure Limited NovoCure Limited Omada Health Inc. Omada Health Inc. Regentis Biomaterials Ltd. Regentis Biomaterials... Sutro Biopharma Inc. Sutro Biopharma Inc. Gregory K. Hinckley Gregory K. Hinckley Jeryl L. Hilleman Jeryl L. Hilleman John Gordon Freund John Gordon Freund Keith Valentine Keith Valentine Laura Francis Laura Francis Mika Nishimura Mika Nishimura Thomas A. West Thomas A. West SI-BONE Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$10,665,393
105 sales by 7 insiders
Date Insider Transaction Shares Price Value
Sep 1, 2026 Jeffrey W. Dunn Director Option exercise +18,633 $4.68 $87,202
Sep 1, 2026 Jeffrey W. Dunn Director Option exercise +1,367 $4.68 $6,398
Sep 1, 2026 Jeffrey W. Dunn Director Open-market sale −18,633 $18.91 $352,313
Sep 1, 2026 Jeffrey W. Dunn Director Open-market sale −1,367 $18.91 $25,847
Aug 24, 2026 Laura Francis Director, Officer (Chief Executive Officer) Open-market sale −25,972 $20.12 $522,596
Aug 24, 2026 Maheshwari Anshul Officer (Chief Op & Financial Officer) Open-market sale −11,636 $20.11 $233,971
Aug 21, 2026 Laura Francis Director, Officer (Chief Executive Officer) Open-market sale −3,923 $20.02 $78,538
Aug 21, 2026 Maheshwari Anshul Officer (Chief Op & Financial Officer) Open-market sale −11,228 $20.02 $224,785
Aug 20, 2026 Laura Francis Director, Officer (Chief Executive Officer) Open-market sale −51,884 $19.46 $1,009,663
Aug 19, 2026 Maheshwari Anshul Officer (Chief Op & Financial Officer) Open-market sale −5,747 $19.55 $112,354
Aug 17, 2026 Laura Francis Director, Officer (Chief Executive Officer) Open-market sale −3,892 $18.66 $72,616
Aug 17, 2026 Maheshwari Anshul Officer (Chief Financial Officer) Open-market sale −2,476 $18.68 $46,251
Aug 17, 2026 PISETSKY MICHAEL A. Officer (SVP, Ops & Adm/Chief Legal Ofr) Open-market sale −1,854 $18.62 $34,513
Aug 17, 2026 Laura Francis Director, Officer (Chief Executive Officer) Open-market sale −3,652 $18.66 $68,144
Aug 17, 2026 Maheshwari Anshul Officer (Chief Financial Officer) Open-market sale −2,189 $18.62 $40,764

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.